- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03350087
Efficacy of rTMS and VCT on Upper Limb Function in Patients With Stroke
Efficacy of Repetitive Transcranial Magnetic Stimulation and Virtual Cycling Training on Upper Limb Function in Patients With Stroke
Study Overview
Status
Conditions
Detailed Description
This study aims to 1. identify the immediate effects of different treatment protocols in for UE training in these patients through brain image, motor control and clinical measures; 2. to determine the maintaining therapeutic effects; 3. to elucidate the most optimal treatment protocols; 4. to determine the neuro-motor control mechanism underlying clinical improvement; 5. to determine the clinimetric properties of the brain imaging and motor control measure that are responsive and valid for detecting changes after treatment protocol intervention, and 6. to identify clinical predictors influencing the outcome for treatment protocols.
The research will offer valuable motor control biomarkers for outcome prediction and targeting patients who benefit from new protocols. This project is significant for the translational and evidence-based medicine on stroke neurorehabilitation.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Recruiting
- Chang Gung Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- first stroke
- chronic stroke (onset > 3 months)
- unilateral cerebral lesion with hemiparesis or hemiplegia
- age of 20-80 years
- no epileptic spikes on the EEG
Exclusion Criteria:
- brain stem or cerebellum stroke
- epilepsy
- aneurysm
- arteriovenous malformation
- psychiatric disease
- degenerative disease
- severe cognitive and communicative impairment or aphasia
- severe medical disease
- active medical problems
- metal implant in the body
- pregnancy
- poor cooperation with assessments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: iTBS group
In intermittent theta burst stimulation (iTBS group), they received iTBS (80% of active motor threshold) on affected hemisphere.
|
In intermittent theta burst stimulation pattern (iTBS) will intermittently give a 2 s train of TBS every 10s repeated 2 times for a total of 40 times (low pulse: 1200 pulses in total) Other Names: intermittent theta burst stimulation |
|
Experimental: cTBS group
In continuous theta burst stimulation (cTBS group), they received cTBS (80% of active motor threshold) on unaffected hemisphere.
|
In continuous burst stimulation pattern (cTBS) will intermittently give a cTBS treatment consists of a continuous train of TBS for 40 seconds repeated for 2 times(low pulse: 1200 pulses in total). Other Names: continuous burst stimulation |
|
Experimental: iTBS+cTBS group
Continuous theta burst stimulation (cTBS group) at first followed by intermittent theta burst stimulation (iTBS group).
|
In iTBS+cTBS pattern, continuous cTBS will be followed by intermittent iTBS (low pulse; 1200 pulses in total)
|
|
Sham Comparator: sham TBS group
In sham theta burst stimulation (sham TBS group), they received sham TBS stimulation.
|
In sham burst stimulation pattern (sham TBS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds(almost no pulse: 1200 pulses in total). Other Names: sham theta burst stimulation |
|
Experimental: VCT group
VCT group received the VCT training in addition to traditional rehabilitation.
Each UE VCT session involved upper limb cycling training followed by UE training in addition to home program.
The cycling program consisted of a warm-up exercise, twenty repetitions of hand push-up movements in the sitting position, UE cycling, and a cool-down exercise.
|
The UE VCT programs were conducted three times per week, for 12 weeks. Each UE VCT session involved upper limb cycling training followed by UE training in addition to home program. The cycling program consisted of a warm-up exercise, twenty repetitions of hand push-up movements in the sitting position, UE cycling, and a cool-down exercise. The warm-up and cool-down exercises involved stretching and relaxing the head, neck, and the upper and lower body. Other Names: The upper extremity programs virtual cycling training program |
|
Experimental: VCT+optimal rTMS group
VCT+optimal rTMS group received the VCT training and optimal rTMS in addition to traditional rehabilitation.
|
In VCT+optimal rTMS group, VCT will be combined with optimal rTMS, which has the best outcome in phase 1.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline of mechanical measurement for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Kinematic analysis for upper limb
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of severity for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Brunnstrom stage classification(by severity from stage 1 to stage 6), Modified Ashworth Scale (tension of upper limb from min(0) to max (4)) and National Institute of Health Stroke Scale (severity from min(0) to max(4))
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of Muscle tone measurement for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Muscle tone
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of Muscle strength measurement for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Muscle strength
|
baseline, after 3 weeks of treatment, 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline of body composition for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
InBodyS10 Body Composition Analyzer
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of activity for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Barthel Index
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of ABAS for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Adaptive behavior assessment system
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of quality of life for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Stroke Impact Scale
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of WMFT for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Wolf motor function test
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of MAL for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Motor activity log
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of TUG for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Timed 'Up & Go' test
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of FIM for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Functional Independence Measure
|
baseline, after 3 weeks of treatment, 3 months
|
|
Change from baseline of participation for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
|
Nottingham Health Profile
|
baseline, after 3 weeks of treatment, 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 104-8816A3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Vascular Accident
-
Sunnyview Rehabilitation HospitalGaylord HospitalCompletedStroke | Stroke, Acute | Cerebral Vascular Accident | Cerebral Vascular Accident (CVA)/StrokeUnited States
-
Universidade do PortoRISE Study Group; Hospital de Sao Joao, PortoCompletedCerebral Vascular Accident (CVA)/StrokePortugal
-
University Hospital, Strasbourg, FranceCompletedCerebral Vascular Accident (CVA)France
-
Fortaleza UniversityCompletedHemiplegia | Cerebrovascular Accident
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...CompletedStroke | Vascular Accident, Brain | Stroke, Acute | Cerebrovascular Accident | Cerebral Stroke | Cerebrovascular Stroke | Cerebrovascular Accident, Acute | Apoplexy | CVA | Cerebrovascular ApoplexyCanada
-
Shirley Ryan AbilityLabActive, not recruiting
-
Shirley Ryan AbilityLabMidwestern UniversityCompletedCerebral Vascular AccidentUnited States
-
China Medical University HospitalTerminated
-
Tianjin Medical University General HospitalCompletedStroke | Stroke, Acute | Cerebral Stroke | Ischemic Cerebrovascular Accident | Vascular AccidentChina
-
Centre Hospitalier Universitaire DijonRecruiting
Clinical Trials on intermittent theta burst stimulation
-
Douglas Mental Health University InstituteCentre de recherche CERVO; Centre de Recherche de l'Institut Universitaire... and other collaboratorsRecruitingSchizophrenia and Predominant Negative SymptomsCanada
-
Moscow Scientific and Practical Center of Medical...Not yet recruitingIschemic Stroke | Upper Limb Motor ImpairmentRussia
-
Hannover Medical SchoolRecruitingSchizophrenia PatientsGermany
-
University of New MexicoNew Mexico VA Healthcare SystemRecruitingPosttraumatic Stress DisorderUnited States
-
Changping LaboratoryNot yet recruitingAphasia | Stroke, Ischemic
-
Bradley HospitalRecruitingWorking MemoryUnited States
-
Erika ForbesNational Institute of Mental Health (NIMH)Completed
-
Izmir Katip Celebi UniversityRecruitingPain | Fibromyalgia | Transcranial Magnetic Stimulation RepetitiveTurkey
-
Sunnybrook Health Sciences CentreRecruitingPost Concussion SyndromeCanada